These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 30798111)

  • 1. PD-1 inhibitor-associated severe myasthenia gravis with necrotizing myopathy and myocarditis.
    So H; Ikeguchi R; Kobayashi M; Suzuki M; Shimizu Y; Kitagawa K
    J Neurol Sci; 2019 Apr; 399():97-100. PubMed ID: 30798111
    [No Abstract]   [Full Text] [Related]  

  • 2. Nivolumab-associated myositis myocarditis and myasthenia and anti-striated muscle antibodies.
    Fazal M; Prentice DA; Kho LK; Fysh E
    Intern Med J; 2020 Aug; 50(8):1003-1006. PubMed ID: 33306231
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Not Available].
    Nihon Rinsho Meneki Gakkai Kaishi; 2017; 40(4):263b. PubMed ID: 29176295
    [No Abstract]   [Full Text] [Related]  

  • 4. Presence of antibodies to striated muscle and acetylcholine receptor in association with occurrence of myasthenia gravis with myositis and myocarditis in a patient with melanoma treated with an anti-programmed death 1 antibody.
    Shirai T; Kiniwa Y; Sato R; Sano T; Nakamura K; Mikoshiba Y; Ohashi N; Sekijima Y; Okuyama R
    Eur J Cancer; 2019 Jan; 106():193-195. PubMed ID: 30528803
    [No Abstract]   [Full Text] [Related]  

  • 5. Neuromuscular adverse events associated with anti-PD-1 monoclonal antibodies: Systematic review.
    Johansen A; Christensen SJ; Scheie D; Højgaard JLS; Kondziella D
    Neurology; 2019 Apr; 92(14):663-674. PubMed ID: 30850443
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fatal myasthenia gravis (MG) associated with myositis and myocarditis in a patient with pre-existing MG treated by adjuvant nivolumab for a stage III melanoma.
    Emile J; Cauquil C; Carpentier D; Routier E; Robert C
    Eur J Cancer; 2024 Jul; 205():114098. PubMed ID: 38761774
    [No Abstract]   [Full Text] [Related]  

  • 7. [A case of anti-titin antibody positive nivolumab-related necrotizing myopathy with myasthenia gravis].
    Isami A; Uchiyama A; Shimaoka Y; Suzuki S; Kawachi I; Fujita N
    Rinsho Shinkeigaku; 2019 Jul; 59(7):431-435. PubMed ID: 31243249
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fatal myocarditis and rhabdomyolysis induced by nivolumab during the treatment of type B3 thymoma.
    Chen Q; Huang DS; Zhang LW; Li YQ; Wang HW; Liu HB
    Clin Toxicol (Phila); 2018 Jul; 56(7):667-671. PubMed ID: 29126352
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Myasthenia Gravis Induced by Immune Checkpoint Inhibitors.
    Becquart O; Lacotte J; Malissart P; Nadal J; Lesage C; Guillot B; Du Thanh A
    J Immunother; 2019 Oct; 42(8):309-312. PubMed ID: 31246640
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Myasthenia gravis and myopathy after nivolumab treatment for non-small cell lung carcinoma: A case report.
    Kim JS; Nam TS; Kim J; Kho BG; Park CK; Oh IJ; Kim YC
    Thorac Cancer; 2019 Oct; 10(10):2045-2049. PubMed ID: 31436031
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Myositis as a neuromuscular complication of immune checkpoint inhibitors.
    Vermeulen L; Depuydt CE; Weckx P; Bechter O; Van Damme P; Thal DR; Claeys KG
    Acta Neurol Belg; 2020 Apr; 120(2):355-364. PubMed ID: 31993961
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Severe Exacerbation of Myasthenia Gravis Associated with Checkpoint Inhibitor Immunotherapy.
    Cooper DS; Meriggioli MN; Bonomi PD; Malik R
    J Neuromuscul Dis; 2017; 4(2):169-173. PubMed ID: 28505981
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute Lymphocytic Myocarditis With Anti-PD-1 Antibody Nivolumab.
    Tadokoro T; Keshino E; Makiyama A; Sasaguri T; Ohshima K; Katano H; Mohri M
    Circ Heart Fail; 2016 Oct; 9(10):. PubMed ID: 27650418
    [No Abstract]   [Full Text] [Related]  

  • 14. Abatacept for Severe Immune Checkpoint Inhibitor-Associated Myocarditis.
    Salem JE; Allenbach Y; Vozy A; Brechot N; Johnson DB; Moslehi JJ; Kerneis M
    N Engl J Med; 2019 Jun; 380(24):2377-2379. PubMed ID: 31189043
    [No Abstract]   [Full Text] [Related]  

  • 15. Nivolumab and Ipilimumab-induced myositis and myocarditis mimicking a myasthenia gravis presentation.
    Valenti-Azcarate R; Esparragosa Vazquez I; Toledano Illan C; Idoate Gastearena MA; Gállego Pérez-Larraya J
    Neuromuscul Disord; 2020 Jan; 30(1):67-69. PubMed ID: 31839404
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PD-1 Inhibitor-associated Myopathies: Emerging Immune-mediated Myopathies.
    Liewluck T; Kao JC; Mauermann ML
    J Immunother; 2018 May; 41(4):208-211. PubMed ID: 29200081
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Late-Onset Fulminant Myocarditis With Immune Checkpoint Inhibitor Nivolumab.
    Yamaguchi S; Morimoto R; Okumura T; Yamashita Y; Haga T; Kuwayama T; Yokoi T; Hiraiwa H; Kondo T; Sugiura Y; Watanabe N; Kano N; Kohno K; Fukaya K; Sawamura A; Yokota K; Ishii H; Nakaguro M; Akiyama M; Murohara T
    Can J Cardiol; 2018 Jun; 34(6):812.e1-812.e3. PubMed ID: 29801747
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vitiligo under anti-programmed cell death-1 therapy is associated with increased survival in melanoma patients.
    Nardin C; Jeand'heur A; Bouiller K; Valnet-Rabier MB; Dresco F; Castagna J; Mareschal A; Carlet C; Nerich V; Limat S; Puzenat E; Aubin F
    J Am Acad Dermatol; 2020 Mar; 82(3):770-772. PubMed ID: 31734192
    [No Abstract]   [Full Text] [Related]  

  • 19. Severe colitis after PD-1 blockade with nivolumab in advanced melanoma patients: potential role of Th1-dominant immune response in immune-related adverse events: two case reports.
    Yoshino K; Nakayama T; Ito A; Sato E; Kitano S
    BMC Cancer; 2019 Oct; 19(1):1019. PubMed ID: 31664934
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dermatomyositis associated with nivolumab therapy for melanoma: a case report and review of the literature.
    Messer A; Drozd B; Glitza IC; Lu H; Patel AB
    Dermatol Online J; 2020 Aug; 26(8):. PubMed ID: 32941716
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.